Your browser doesn't support javascript.
loading
Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: Choice of another tumour necrosis factor inhibitor or a biologic of different mode of action?
Shipa, Muhammad R A; Di Cicco, Maria; Balogh, Emese; Nitu, Naila A; Mainuddin, M D; Bhadauria, Naveen; Mukerjee, Dev; Roussou, Euthalia.
Afiliação
  • Shipa MRA; Centre for Rheumatology, Division of Medicine, University College London, London, UK; Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF, UK.
  • Di Cicco M; Department of Rheumatology, Barking Havering and Redbridge University Hospitals NHS Trust, London, UK.
  • Balogh E; Department of Rheumatology, Barking Havering and Redbridge University Hospitals NHS Trust, London, UK.
  • Nitu NA; Department of Rheumatology, North Middlesex University Trust, London, UK.
  • Mainuddin MD; Department of Rheumatology, North Middlesex University Trust, London, UK.
  • Bhadauria N; Department of Rheumatology, North Middlesex University Trust, London, UK.
  • Mukerjee D; Department of Rheumatology, North Middlesex University Trust, London, UK.
  • Roussou E; Department of Rheumatology, Barking Havering and Redbridge University Hospitals NHS Trust, London, UK.
Mod Rheumatol ; 33(4): 700-707, 2023 Jul 04.
Article em En | MEDLINE | ID: mdl-35920402

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Inibidores do Fator de Necrose Tumoral Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos / Inibidores do Fator de Necrose Tumoral Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article